Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for Parkinson's: drug pump studied for earlier use

NCT ID NCT06916507

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well the drug combination Foslevodopa/Foscarbidopa works for people with early advanced Parkinson's disease in everyday German clinics. About 125 adults aged 18-64 who are already prescribed this drug will be followed for up to 12 months. Researchers will track changes in 'OFF' time (when symptoms return between doses), quality of life, and work ability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Foslevodopa/Foscarbidopa (a drug combination given as a continuous infusion under the skin)
What this could lead to
If successful, this study could show that starting this treatment earlier in advanced Parkinson's helps control motor symptoms and improves daily life and work ability.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It is small (125 people) and only follows patients for 12 months, so long-term benefits or risks remain unclear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE

Contacts and locations

Locations

  • Asklepios Fachklinikum Stadtroda /ID# 274162

    RECRUITING

    Stadtroda, Thuringia, 07646, Germany

  • Cellitinnen-NTC Neurologisches Therapiecentrum /ID# 277865

    RECRUITING

    Cologne, North Rhine-Westphalia, 50668, Germany

  • Klinikum Dortmund Klinikzentrum Mitte /ID# 280222

    RECRUITING

    Dortmund, North Rhine-Westphalia, 44137, Germany

  • Klinikum Ernst von Bergmann /ID# 274176

    RECRUITING

    Potsdam, Brandenburg, 14467, Germany

  • Klinikum Ingolstadt /ID# 280573

    RECRUITING

    Ingolstadt, Bavaria, 85049, Germany

  • Klinikum Lippe Detmold /ID# 279451

    RECRUITING

    Detmold, North Rhine-Westphalia, 32756, Germany

  • Klinikum der Universitaet Muenchen Grosshadern /ID# 274168

    RECRUITING

    Munich, Bavaria, 81337, Germany

  • Knappschaftskrankenhaus Bottrop /ID# 274284

    RECRUITING

    Bottrop, North Rhine-Westphalia, 46242, Germany

  • Krankenhaus Martha-Maria Halle-Dolau /ID# 274174

    RECRUITING

    Halle, Saxony-Anhalt, 06120, Germany

  • Parkinson-Klinik Ortenau GmbH&Co KG /ID# 274161

    RECRUITING

    Wolfach, Baden-Wurttemberg, 77709, Germany

  • Praxis MD Oehlwein /ID# 274222

    RECRUITING

    Gera, Thuringia, 07551, Germany

  • Praxis Prof. Kassubek/Prof. Riecker /ID# 274165

    RECRUITING

    Ulm, Baden-Wurttemberg, 89073, Germany

  • Universitaetskliniken Giessen und Marburg /ID# 274224

    RECRUITING

    Marburg, Hesse, 35043, Germany

  • Universitaetsklinikum Carl Gustav Carus Dresden /ID# 274167

    RECRUITING

    Dresden, Saxony, 01307, Germany

  • Universitaetsklinikum Erlangen /ID# 280831

    RECRUITING

    Erlangen, Bavaria, 91054, Germany

  • Universitaetsklinikum Heidelberg /ID# 274164

    RECRUITING

    Heidelberg, Baden-Wurttemberg, 69120, Germany

  • Universitaetsklinikum Tuebingen /ID# 275828

    RECRUITING

    Tübingen, Baden-Wurttemberg, 72076, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.